These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5298460)

  • 1. The effect of acute and prolonged cold exposure on the brain amine depleting action of reserpine.
    Ingenito AJ
    Arch Int Pharmacodyn Ther; 1967 Apr; 166(2):324-32. PubMed ID: 5298460
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of brain norepinephrine in audiogenic seizure in the rat.
    Jobe PC; Picchioni AL; Chin L
    J Pharmacol Exp Ther; 1973 Jan; 184(1):1-10. PubMed ID: 4686009
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of electroconvulsive shock and prior stress on brain amine levels.
    Nielson HC; Fleming RM
    Exp Neurol; 1968 Jan; 20(1):21-30. PubMed ID: 5300035
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of mediodespidine on brain monoamines and behavior in mice].
    Dlabac A; Masek K; Trcka V
    Act Nerv Super (Praha); 1967 Aug; 9(3):316-7. PubMed ID: 5299186
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the effects of losulazine and reserpine on central aminergic neurons.
    Pan JT; Hooth MJ; Lookingland KJ; Moore KE; Marks TA
    Toxicol Appl Pharmacol; 1993 Nov; 123(1):26-33. PubMed ID: 8236258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental study on the mechanism of depressogenic action of apomorphine and reserpine.
    Benesová O; Benes V
    Act Nerv Super (Praha); 1972 Nov; 14(4):269-72. PubMed ID: 4673427
    [No Abstract]   [Full Text] [Related]  

  • 7. 5-Hydroxytryptophan reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO; Seiden LS
    Physiol Behav; 1973 Jan; 10(1):9-12. PubMed ID: 4540511
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the effectiveness of deserpidine, reserpine, and alpha-methyltyrosine on brain biogenic amines.
    Fulton SC; Healy MD
    Fed Proc; 1976 Dec; 35(14):2558-62. PubMed ID: 11134
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of reserpine, alpha-methyl-m-tyrosine, prenylamine, and guanethidine on metrazol-convulsions and the brain monoamine level in mice.
    Pfeifer AK; Galambos E
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):201-11. PubMed ID: 6030237
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavior and biochemical effects of preferentially protecting monoamines in the brain against the action of reserpine.
    Butcher LL; Rhodes DL; Yuwiler A
    Eur J Pharmacol; 1972 May; 18(2):204-12. PubMed ID: 4537669
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Determination of noradrenaline, dopamine, serotonin, 5-hydroxyindoleacetic acid, tyrosine and tryptophane in the isolated perfused rat brain.
    Niemeyer DH; Krieglstein J
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R71. PubMed ID: 4276624
    [No Abstract]   [Full Text] [Related]  

  • 12. The inverse relationship between the activity of pyridoxal kinase and the level of biogenic amines in rabbit brain.
    Ebadi MS; Russell RL; McCoy EE
    J Neurochem; 1968 Jul; 15(7):659-65. PubMed ID: 5302709
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine and noradrenaline in the salivary glands and brain of the tick, Boophilus microplus: effect of reserpine.
    Megaw MW; Robertson HA
    Experientia; 1974 Nov; 30(11):1261-2. PubMed ID: 4435160
    [No Abstract]   [Full Text] [Related]  

  • 14. Blockade of L-dopa reversal of reserpine-induced conditioned avoidance response suppression by disulfiram.
    Seiden LS; Peterson DD
    J Pharmacol Exp Ther; 1968 Sep; 163(1):84-90. PubMed ID: 5673718
    [No Abstract]   [Full Text] [Related]  

  • 15. Synergism of imipramine and desmethylimipramine with reserpine in the frog. Interaction with 5-hydroxytryptophan and 2-bromolysergid diethylamide (BOL-148).
    Lapin IP; Osipova SV; Uskova NV; Stabrovski EM
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):37-49. PubMed ID: 5303117
    [No Abstract]   [Full Text] [Related]  

  • 16. The anticonvulsant action of inhibitors of carbonic anhydrase: relation to endogenous amines in brain.
    Gray WD; Rauh CE
    J Pharmacol Exp Ther; 1967 Jan; 155(1):127-34. PubMed ID: 6017334
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective protection of 5-hydroxytryptamine stores against the action of reserpine by treatment with 5-hydroxytryptophan.
    Carlsson A
    J Pharm Pharmacol; 1967 Nov; 19(11):783-4. PubMed ID: 4383709
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor. III. Effects on endogenous biogenic amine levels in rats.
    Ishii Y; Homma M; Yoshikawa A; Umezawa H
    Arzneimittelforschung; 1975 Mar; 25(3):383-5. PubMed ID: 1174036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamine levels in the whole brain and the probability of memory formation are not related.
    Palfai T; Brown OM; Walsh TJ
    Pharmacol Biochem Behav; 1978 Jun; 8(6):717-21. PubMed ID: 308663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin.
    Sanders-Bush E; Sulser F
    J Pharmacol Exp Ther; 1970 Nov; 175(2):419-26. PubMed ID: 5312363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.